A Roadmap for Advancing RSV Maternal Immunization

This report, developed by the Advancing Maternal Immunization (AMI) collaboration, describes the activities required in the near- and mid-to long-term to generate key evidence and achieve the necessary conditions for advancing respiratory syncytial virus (RSV) maternal immunization in low- and middle-income countries. It is a companion to AMI's Advancing RSV Maternal Immunization: A Gap Analysis Report, which describes the evidence, information, and policy needs of global and country decision-makers, public health program planners, and implementers who might be involved in decision-making and introducing maternal RSV vaccines.

AMI is a collaboration of cross-sectoral experts convened by PATH and WHO with the purpose of advancing RSV maternal immunization.

Corporate author(s): PATH

Publication date: October 2018

Available materials

  1. English

    1. A Roadmap for Advancing RSV Maternal Immunization 3.3 MB PDF

  2. English

    1. Advancing Maternal Immunization: A Roadmap Brief

      This document is a summary of the A Roadmap for Advancing RSV Maternal Immunization report.
    2. Advancing RSV Maternal Immunization: A Gap Analysis Report

      This report is a companion to and the basis for A Roadmap for Advancing RSV Maternal Immunization.